Delivery Order SPE2DB22D3301-SPE2DB23FZ0CG
Award Date 6/26/23
Potential Completion Date 6/27/23
Potential Value $12K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $10,688 to Amerisourcebergen Drug Corporation to supply 50 mg vials of the drug Activase. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 25 to June 26, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor on this delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $38,853.47 to Amerisourcebergen Drug Corporation to supply 4561425706 units of 50 mg vials of the drug Activase. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 7-10, 2023. This delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to support the medical...
- The Defense Logistics Agency awarded a $34,843 delivery order to Amerisourcebergen Drug Corporation for 4561307160 Activase 100 mg vials. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by June 22, 2023 in support of DLA's medical supply procurement programs. Amerisourcebergen will serve as the prime contractor, with no subcontractors mentioned. The order was awarded off the DLA's Pharmaceutical Prime Vendor contract vehicle and falls under the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $10,000 to Amerisourcebergen Drug Corporation to supply 50 milligram vials of the drug Activase. The single day order is to be fulfilled on August 9-10, 2023 with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will perform as the prime contractor, with their parent company listed as Amerisourcebergen Corporation. The Defense Logistics Agency is the funding...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $20,940 to Amerisourcebergen Drug Corporation to supply 100 mg vials of the pharmaceutical ACTIVASE. The order is to be performed at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with work scheduled to be completed by August 1, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the ordered products to...
- The Defense Logistics Agency awarded a $27,071.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Activase 50 mg vials, with an ultimate completion date of September 25, 2025. This competitively awarded contract, with no set-aside designation, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $20,483.72 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, valued at $12,474.24 under a firm fixed-price contract. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,034.80 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of December 10, 2025. This firm fixed-price contract, awarded on December 9, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $60,767.26 for 100 mg vials of Activase on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price, non-set-aside contract represents a pediatric delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled...